NCT00698763|CompletedPhase 2
Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables
Electro
Loading search results
Electro
Sponsor study identifier
interventional
32
4 countries
7
Study Start
August 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2009
Actual (reported)Study Completion
September 2009
Actual (reported)The primary objective is to explore the safety of low doses of oral levosimendan in patients with recent history of an ischaemic cerebrovascular event (stroke or TIA). The main focus will be on the evaluation of proarrhythmic potential of the different dose regimens.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 12, 2008
Actual (reported)June 17, 2008
Actual (reported)August 2008
Date type not reportedThis date has not been verified as actual or estimated.
April 2009
Actual (reported)September 2009
Actual (reported)24-h Holter reporting
every 2 weeks
Levosimendan
Placebo
from 0.125 mg to 2 mg in escalating doses
Placebo capsules are identical in appearance to active capsules
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Helsinki University Hospital (HUCH)
Helsinki, Finland
Turku University Hospital (TYKS)
Turku, 20521, Finland
Heidelberg University Clinic
Heidelberg, Germany
Debrecen University
Debrecen, Hungary
Sahlgrenska University Hospital, Dept of Neurology
Gothenburg, 413 45, Sweden
University Hospital, Neurologmottagningen
Linköping, 581 85, Sweden
Umeå University Hospital, Strokecenter NVS
Umeå, 901 85, Sweden
Kivikko M, Kuoppamaki M, Soinne L, Sundberg S, Pohjanjousi P, Ellmen J, Roine RO. Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study. Curr Ther Res Clin Exp. 2015 Jan 29;77:46-51. doi: 10.1016/j.curtheres.2015.01.001. eCollection 2015 Dec.
Irja Korpela
Orion Corporation, Orion Pharma
Risto O. Roine, M.D., Ph.D.
Turku University Hospital
32 participants (actual enrollment reported by the registry).
First Submitted
June 12, 2008
First Posted
June 17, 2008
Study Start
August 2008
Date type not reportedThis date has not been verified as actual or estimated.
E-Selectin Nasal Spray to Prevent Stroke Recurrence
Contact the study team to confirm eligibility.
Primary Completion
April 2009
Actual (reported)Study Completion
September 2009
Actual (reported)Last Updated
November 25, 2009
Record last verified: 2009-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: